DK1830835T3 - Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter - Google Patents

Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter

Info

Publication number
DK1830835T3
DK1830835T3 DK04802397.2T DK04802397T DK1830835T3 DK 1830835 T3 DK1830835 T3 DK 1830835T3 DK 04802397 T DK04802397 T DK 04802397T DK 1830835 T3 DK1830835 T3 DK 1830835T3
Authority
DK
Denmark
Prior art keywords
glycosaminoglycan
proteoglycan
preparation
receptor antagonist
vanilloid receptor
Prior art date
Application number
DK04802397.2T
Other languages
English (en)
Inventor
Dominik Meyer
Original Assignee
Mestex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mestex Ag filed Critical Mestex Ag
Application granted granted Critical
Publication of DK1830835T3 publication Critical patent/DK1830835T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK04802397.2T 2004-12-28 2004-12-28 Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter DK1830835T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2004/000757 WO2006069452A1 (de) 2004-12-28 2004-12-28 Verwendung eines vanilloidrezeptoragonisten zusammen mit einem glycosaminoglycan oder proteoglycan für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels

Publications (1)

Publication Number Publication Date
DK1830835T3 true DK1830835T3 (da) 2012-07-02

Family

ID=34959550

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04802397.2T DK1830835T3 (da) 2004-12-28 2004-12-28 Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter

Country Status (11)

Country Link
US (1) US8703741B2 (da)
EP (1) EP1830835B1 (da)
JP (1) JP5080983B2 (da)
AT (1) ATE549018T1 (da)
CA (1) CA2594203C (da)
DK (1) DK1830835T3 (da)
ES (1) ES2384244T3 (da)
PL (1) PL1830835T3 (da)
PT (1) PT1830835E (da)
SI (1) SI1830835T1 (da)
WO (1) WO2006069452A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008057930A2 (en) 2006-11-02 2008-05-15 Aestus Therapeutics, Inc. Methods of treating neuropathic pain with retinoic acid receptor agonists
US8870876B2 (en) 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
CA2891218A1 (en) 2012-11-12 2014-05-15 Api Genesis, Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
DK2956440T3 (da) 2013-02-08 2018-05-28 Gen Mills Inc Næringsmiddelprodukter med reduceret natriumindhold
EP2818162A1 (en) * 2013-06-28 2014-12-31 Encubator AB A composition for use in the treatment of intervertebral disc-related pain
US20150133561A1 (en) * 2013-11-12 2015-05-14 Vizuri Health Sciences Llc Aqueous based capsaicinoid formulations and methods of manufacture and use
MX2016013280A (es) 2014-04-15 2017-04-27 Vizuri Health Sciences Llc Composiciones topicas para el alivio del dolor, manufactura y uso.
MX2019005202A (es) 2016-11-02 2019-10-14 Centrexion Therapeutics Corp Formulaciones inyectables de capsaicina acuosa estable y usos medicos de los mismos.
JP7282736B2 (ja) 2017-07-20 2023-05-29 セントレクシオン セラピューティクス コーポレイション カプサイシンを使用した疼痛の治療のための方法及び組成物
CN111315360A (zh) * 2017-09-11 2020-06-19 索伦托治疗有限公司 树脂毒素制剂
US11254659B1 (en) 2019-01-18 2022-02-22 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions
US11447444B1 (en) 2019-01-18 2022-09-20 Centrexion Therapeutics Corporation Capsaicinoid prodrug compounds and their use in treating medical conditions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8501723L (sv) * 1985-04-09 1986-10-10 Pharmacia Ab Preparation att anvendas vid behandling av ledinflammation
WO1998040070A1 (en) * 1997-03-13 1998-09-17 Campbell James N Compositions containing capsaicin or capsaicin analogues and a local anesthetic
WO2003099013A1 (en) * 2000-01-24 2003-12-04 Omni Nutraceuticals, Inc. Acetaminophen/non-steroidal anti-inflamatory drug-glucosamine composition
US6689399B1 (en) * 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
US20030104085A1 (en) * 2001-12-05 2003-06-05 Yeomans David C. Methods and compositions for treating back pain
US20040156931A1 (en) * 2002-12-18 2004-08-12 Algorx Administration of capsaicinoids
PT1605956E (pt) * 2002-12-18 2016-03-09 Centrexion Therapeutics Corp Administração de capsaicinóides para o tratamento da osteoartrite
US20040254142A1 (en) * 2003-06-12 2004-12-16 Robert Kovler Arthritic and joint condition formulation
US20050232980A1 (en) * 2004-04-15 2005-10-20 Chen Andrew L Transdermal chondroitin and glucosamine delivery system and method of use
WO2006066419A1 (de) 2004-12-22 2006-06-29 Mestex Ag Mischung eines vanilloidrezeptoragonisten mit einer nervenregenerationshemmenden substanz, ihre verwendung für die herstellung eines schmerzmittels und verfahren zur applikation dieses mittels

Also Published As

Publication number Publication date
US20080153780A1 (en) 2008-06-26
JP2008525505A (ja) 2008-07-17
WO2006069452A1 (de) 2006-07-06
CA2594203A1 (en) 2006-07-06
ES2384244T3 (es) 2012-07-02
ATE549018T1 (de) 2012-03-15
US8703741B2 (en) 2014-04-22
SI1830835T1 (sl) 2012-07-31
PL1830835T3 (pl) 2012-08-31
EP1830835B1 (de) 2012-03-14
CA2594203C (en) 2014-04-29
JP5080983B2 (ja) 2012-11-21
EP1830835A1 (de) 2007-09-12
PT1830835E (pt) 2012-06-25

Similar Documents

Publication Publication Date Title
DK1830835T3 (da) Anvendelse af en vanilloid receptorantagonist sammen med et glycosaminoglycan eller proteoglycan til fremstilling af et middel til behandling af smerter
MX2009006751A (es) Compuestos agonistas y antagonistas del receptor de esfingosina-1-fosfato.
DE602005021696D1 (de) Indazolcarbonsäureamidverbindungen
CL2011000976A1 (es) Compuestos derivados de isonicotinamida y carboxamida, antagonistas de los receptores de orexina; composicion farmaceutica que los comprende; y su uso para la prevencion de un trastorno del sueno.
DE602007012072D1 (de) Orantagonisten
ATE441646T1 (de) 5-ht4-rezeptoragonistenverbindungen
WO2007098474A8 (en) Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
CL2008000947A1 (es) Uso de un antagonista de la proteina beta-klotho (klb) para tratar trastornos asociados a la expresion o actividad de klb.
EA200870410A1 (ru) Антагонисты киназы
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
DE602005014566D1 (de) Chinolinon-carboxamid-verbindungen
CL2007001451A1 (es) Compuestos derivados de [1,2,3]-tiazol-4-ilmetoxilo, agonista del receptor farnesoide x (fxr); composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar dislipidemia y enfermedades relacionadas.
CL2008002450A1 (es) Compuestos derivados de fenil-pirrolidin-eter, con actividad antagonista de los receptores nk3; procedimientos para su preparacion; composicion farmaceutica; y el uso de los compuestos en el tratamiento de depresion, dolor, psicosis, entre otras.
DE602007006961D1 (de) Cgrp-rezeptorantagonisten
CR9716A (es) Bencimidazoles sustituidos como inhibidores de cinasa
NO20074567L (no) Glucagonreseptorantagoniser, fremstilling og terapeutisk anvendelse
CR10694A (es) Compuestos antagonistas del receptor de glucagon, composiciones que contienen dichos compuestos y procedimientos de uso
ME01532B (me) Jedinjenja
ECSP099675A (es) Compuestos heterocíclicos, composición y métodos de uso
CL2011000071A1 (es) Compuestos derivados de oxazolopirimidinas, antagonistas del receptor edg-1; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades cardiovasculares, trombosis, aterosclerosis, hipertension, diabetes, enfermedades renales, respiratorias, inflamatorias y autoinmunes, entre otras.
EA200800525A1 (ru) Соединения пиримидина в качестве модуляторов серотониновых рецепторов
ATE458740T1 (de) 1,4,5,6,7,8-hexahydro-1,2,5-triaza-azulen- derivate als orexinrezeptor-antagonisten
BRPI1013777A8 (pt) Compostos agonistas do receptor 5-ht4 para tratamento de distúrbios cognitivos.
EA201100303A1 (ru) Производные пиразоло[5,1-b]оксазола в качестве антагонистов cfr1
ECSP088740A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios